FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin <i>via</i> SHP dependent inhibition of Bcl-xL expression

Wei Wang(Shanghai Jiao Tong University), Jian Wang(Tianjin Medical University Cancer Institute and Hospital)
Oncotarget
April 25, 2016
Cited by 28


Related Papers